Company Analysis

Milestone Pharmaceuticals Inc. (MIST)

Nasdaq: MIST · Pharmaceutical Preparations · Montreal, QC · filing with the SEC since 2007
Grade4.5
◀ Past 5.0● Present 4.1▶ Future 4.4
6 est.

Who runs Milestone Pharmaceuticals Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Oliveto Joseph
President and CEO. First filing May 2019, latest Apr 20, 2026, 3 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
22 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Oliveto JosephPresident and CEOMay 2019Apr 20, 20265 · $600,000
Sandoval David I.GC & Chief Compliance OfficerMar 2026Mar 23, 2026none
Hasija AmitCFO & EVP of Corp. DevelopmentSep 2019Feb 5, 20262 · $200,000
Nelson Jeffrey EdwardChief Operating OfficerAug 2022Feb 5, 20262 · $200,000
Bharucha DavidChief Medical OfficerFeb 2022Feb 5, 20262 · $200,000
Muller LorenzChief Commercial OfficerMay 2019Feb 5, 20262 · $100,000
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Duty StuartdirectorJul 2024Jun 12, 2026none
Fischer Seth H. Z.directorMar 2023Jun 12, 2026none
Giles Lisa M.directorOct 2020Jun 12, 2026none
Papa Joseph CdirectorSep 2024Jun 12, 2026none
Saik AndrewdirectorJul 2024Jun 12, 2026none
Tomsicek Michael JohndirectorMay 2019Jun 12, 2026none
Wills Robert JamesdirectorOct 2020Jun 12, 2026none
Liebert Debra K.directorMay 2019Jul 15, 2025none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MIST · research, not advice